GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Price-to-Operating-Cash-Flow

Oncodesign Precision Medicine (XPAR:ALOPM) Price-to-Operating-Cash-Flow : (As of Jun. 23, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Price-to-Operating-Cash-Flow?

As of today (2025-06-23), Oncodesign Precision Medicine's share price is €0.283. Oncodesign Precision Medicine's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Hence, Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:ALOPM's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.08
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Oncodesign Precision Medicine's Cash Flow from Operations per share for the six months ended in Dec. 2024 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.

Oncodesign Precision Medicine Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Price-to-Operating-Cash-Flow Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
- - - - -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow falls into.


;
;

Oncodesign Precision Medicine Price-to-Operating-Cash-Flow Calculation

Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.283/0
=

Oncodesign Precision Medicine's Share Price of today is €0.283.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncodesign Precision Medicine's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Oncodesign Precision Medicine Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
XPAR:ALTAO XPAR:ALTME XPAR:ALTHX XPAR:ALINT XPAR:ALVIO XPAR:ALBPS XPAR:ALPAT XPAR:ALNFL XPAR:ALNEV XPAR:ALCOX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ZR8:Germany
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines